This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
-Medical News
 Blood Safety News
 NHF and Community News
 Industry News
 Travel Advisory



NHF Announces 2011 NHF/Novo Nordisk Career Development Award Recipient

The National Hemophilia Foundation (NHF) is pleased to announce Jordan A. Shavit, MD, PhD, of the University of Michigan at Ann Arbor, as the recipient of our 2011 NHF/Novo Nordisk Career Development Award (CDA).

The overall objectives of the CDA program are to advance bleeding disorders research by promoting development of novel and innovative studies by established investigators.  Dr. Shavit’s project is the “Identification of Chemical and Genetic Modifiers of Bleeding Disorders Using a Zebrafish Model System.” His research focuses on better understanding the genetic and molecular pathways that modify or regulate hemostasis through the use of a zebrafish model. Specifically, he will utilize zebrafish genetics to potentially identify the modifier genes that result in reduced or absent bleeding.  This innovative research proposal may lead to better therapeutic approaches in the future, especially with regard to screening or potentially tailoring treatment to particular patients.  Through the CDA, Dr. Shavit will receive support for up to three years.

Dr. Shavit received his undergraduate degree in cell and molecular biology from the University of Michigan, and both his MD and PhD from Northwestern University.  Prior to his appointment as an Assistant Professor of Pediatrics and Communicable Diseases at the University of Michigan in 2009, he spent four years as a postdoctoral research fellow at the University of Michigan under the mentorship of Dr. David Ginsburg. Dr. Shavit is also a former NHF-Baxter Clinical Fellow, having received the award in 2006-2008. 

The selection of this award was made through a peer review process conducted by NHF’s Research Review Committee. This volunteer committee consists of both highly experienced clinicians and researchers working in the field of hemostasis. The funding for this award is made possible thanks to a generous grant from Novo Nordisk to NHF’s Research Catalyst Fund.  


This section of our Web site is sponsored by: